Glaucoma Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects | Q BioMed, InMed Pharmaceuticals, ONL Therapeutics, Mitotech, TheratOcular Biotek

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Glaucoma pipeline constitutes 50+ key companies continuously working towards developing 50+ Glaucoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Glaucoma Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Glaucoma Market.

The Glaucoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Glaucoma Pipeline Report: https://www.delveinsight.com/sample-request/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Glaucoma treatment therapies with a considerable amount of success over the years.
• Glaucoma companies working in the treatment market are Q BioMed, InMed Pharmaceuticals, ONL Therapeutics, Mitotech, TheratOcular Biotek Co., Ltd., AbbVie, JeniVision, Qlaris Bio, VivaVivion Biotech, Inc., Nicox, Tarsier Pharma Ltd, Santen Pharmaceutical, and others, are developing therapies for the Glaucoma treatment
• Emerging Glaucoma therapies in the different phases of clinical trials are- MAN-01, INM-088, ONL 1204, Visomitin, TO-O-1001, AGN-193408, JV-GL1, QLS-101, VVN539, NCX 470, TRS01, STN-1012600, and others are expected to have a significant impact on the Glaucoma market in the coming years.
• In November 2023, Using its patented ELUTYXTM bioresorbable hydrogel-based formulation technology, Ocular Therapeutix, Inc. is a biopharmaceutical business dedicated to the formulation, development, and commercialization of cutting-edge medicines for illnesses and disorders of the eye.

Glaucoma Overview
Increased intraocular pressure in the eye can cause glaucoma, a condition that can lead to visual loss. A fundoscopic examination reveals a typical optic nerve head appearance as a result, and a progressive loss of vision follows.

Get a Free Sample PDF Report to know more about Glaucoma Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Glaucoma Drugs Under Different Phases of Clinical Development Include:
• MAN-01: Q BioMed
• INM-088: InMed Pharmaceuticals
• ONL 1204: ONL Therapeutics
• Visomitin: Mitotech
• TO-O-1001: TheratOcular Biotek Co., Ltd.
• AGN-193408: AbbVie
• JV-GL1: JeniVision
• QLS-101: Qlaris Bio
• VVN539: VivaVivion Biotech, Inc.
• NCX 470: Nicox
• TRS01: Tarsier Pharma Ltd
• STN-1012600: Santen Pharmaceutical

Glaucoma Route of Administration
Glaucoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Intravenous
• Subcutaneous
• Oral
• Intramuscular

Glaucoma Molecule Type
Glaucoma Products have been categorized under various Molecule types, such as
• Monoclonal antibody
• Small molecule
• Peptide

Glaucoma Pipeline Therapeutics Assessment
• Glaucoma Assessment by Product Type
• Glaucoma By Stage and Product Type
• Glaucoma Assessment by Route of Administration
• Glaucoma By Stage and Route of Administration
• Glaucoma Assessment by Molecule Type
• Glaucoma by Stage and Molecule Type

DelveInsight's Glaucoma Report covers around 50+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Glaucoma product details are provided in the report. Download the Glaucoma pipeline report to learn more about the emerging Glaucoma therapies at:
https://www.delveinsight.com/sample-request/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Glaucoma Therapeutics Market include:
Key companies developing therapies for Glaucoma are - Aerie Pharmaceuticals Inc., Akorn, Incorporated, Abbvie Inc. (Allergan Plc), Bausch Health (Bausch & Lomb Incorporated), Inotek Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc, Santen Pharmaceutical Co., Ltd., and others.

Glaucoma Pipeline Analysis:
The Glaucoma pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Glaucoma with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Glaucoma Treatment.
• Glaucoma key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Glaucoma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Glaucoma market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Glaucoma drugs and therapies-
https://www.delveinsight.com/sample-request/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Glaucoma Pipeline Market Drivers
• Growing Prevalence of glaucoma, development of novel therapies, growing awareness due to government initiatives and pharmaceutical companies are some of the important factors that are fueling the Glaucoma Market.

Glaucoma Pipeline Market Barriers
• However, high medical cost, side-effects associated with the drugs and other factors are creating obstacles in the Glaucoma Market growth.

Scope of Glaucoma Pipeline Drug Insight
• Coverage: Global
• Key Glaucoma Companies: Q BioMed, InMed Pharmaceuticals, ONL Therapeutics, Mitotech, TheratOcular Biotek Co., Ltd., AbbVie, JeniVision, Qlaris Bio, VivaVivion Biotech, Inc., Nicox, Tarsier Pharma Ltd, Santen Pharmaceutical, and others
• Key Glaucoma Therapies: MAN-01, INM-088, ONL 1204, Visomitin, TO-O-1001, AGN-193408, JV-GL1, QLS-101, VVN539, NCX 470, TRS01, STN-1012600, and others
• Glaucoma Therapeutic Assessment: Glaucoma current marketed and Glaucoma emerging therapies
• Glaucoma Market Dynamics: Glaucoma market drivers and Glaucoma market barriers

Request for Sample PDF Report for Glaucoma Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Glaucoma Report Introduction
2. Glaucoma Executive Summary
3. Glaucoma Overview
4. Glaucoma- Analytical Perspective In-depth Commercial Assessment
5. Glaucoma Pipeline Therapeutics
6. Glaucoma Late Stage Products (Phase II/III)
7. Glaucoma Mid Stage Products (Phase II)
8. Glaucoma Early Stage Products (Phase I)
9. Glaucoma Preclinical Stage Products
10. Glaucoma Therapeutics Assessment
11. Glaucoma Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Glaucoma Key Companies
14. Glaucoma Key Products
15. Glaucoma Unmet Needs
16 . Glaucoma Market Drivers and Barriers
17. Glaucoma Future Perspectives and Conclusion
18. Glaucoma Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Glaucoma Market https://www.delveinsight.com/report-store/glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Glaucoma Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Glaucoma Epidemiology https://www.delveinsight.com/report-store/glaucoma-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Glaucoma Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of heart failure and cardiovascular diseases due to obesity, age, & unhealthy lifestyles and rising demand for organ transplants due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others

B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.